LifeTech Scientific Corp
HKEX:1302

Watchlist Manager
LifeTech Scientific Corp Logo
LifeTech Scientific Corp
HKEX:1302
Watchlist
Price: 1.46 HKD 0.69% Market Closed
Market Cap: 6.4B HKD
Have any thoughts about
LifeTech Scientific Corp?
Write Note

LifeTech Scientific Corp
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

LifeTech Scientific Corp
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
LifeTech Scientific Corp
HKEX:1302
Gross Profit
ÂĄ1B
CAGR 3-Years
14%
CAGR 5-Years
15%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Gross Profit
ÂĄ1.2B
CAGR 3-Years
51%
CAGR 5-Years
48%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Gross Profit
ÂĄ3.6B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
19%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Gross Profit
ÂĄ23.8B
CAGR 3-Years
16%
CAGR 5-Years
19%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Gross Profit
ÂĄ2.1B
CAGR 3-Years
1%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Gross Profit
ÂĄ5.5B
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

LifeTech Scientific Corp
Glance View

Market Cap
6.8B HKD
Industry
Health Care

LifeTech Scientific Corp. is an investment holding company, which engages in the development, manufacture, research, development and market of minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders. The company is headquartered in Shenzhen, Guangdong and currently employs 943 full-time employees. The company went IPO on 2011-11-10. The firm operates through three business segments. The Congenital Heart Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to congenital and structural heart diseases. The Peripheral Vascular Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to peripheral vascular diseases. The Surgical Vascular Repair Business segment is engaged in the research and development, manufacture and trading of devices related to surgical vascular repair.

Intrinsic Value
2.06 HKD
Undervaluation 29%
Intrinsic Value
Price

See Also

What is LifeTech Scientific Corp's Gross Profit?
Gross Profit
1B CNY

Based on the financial report for Jun 30, 2024, LifeTech Scientific Corp's Gross Profit amounts to 1B CNY.

What is LifeTech Scientific Corp's Gross Profit growth rate?
Gross Profit CAGR 5Y
15%

Over the last year, the Gross Profit growth was 7%. The average annual Gross Profit growth rates for LifeTech Scientific Corp have been 14% over the past three years , 15% over the past five years .

Back to Top